31st Oct 2023 13:22
(Alliance News) - Ondine Biomedical Inc on Tuesday said Alberta Health Services has expanded the use of its Steriwave naval photodisinfection technology following a successful pilot at the Mazankowski Alberta Heart Institute.
Shares in the Vancouver-based life sciences company jumped 23% to 12.90 pence each in London on Tuesday afternoon.
Ondine said after a successful pilot study at the Manzankowski Alberta Heart Institute, the device will now be used at the Royal Alexandra Hospital in Edmonton ahead of 3,000 planned orthopaedic surgeries in the next twelve months.
Last week, Ondine reported that Steriwave helped reduce spine surgery infection rates by 67% at Vancouver General Hospital, following an eight-year study conducted by VGH and University of British Columbia hospital.
Steriwave employs patented nasal photodisinfection technology to eliminate bacteria, fungi and viruses located on human tissues.
Chief Executive Officer Carolyn Cross said: "We are very pleased to be collaborating with Alberta Health Services to reduce the incidence of [surgical site infections] in Alberta without generating antibiotic resistance. The successful initial implementation of Steriwave into the pre-surgical treatment protocols at the Mazankowski Alberta Heart Institute has driven rapid adoption of Steriwave for orthopedic surgeries at the Royal Alexandra Hospital."
By Sabrina Penty, Alliance News reporter
Comments and questions to [email protected]
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Related Shares:
Ondine Biomed